Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitric oxide production from hydroxyurea.

S Bruce King1

  • 1Department of Chemistry, Wake Forest University, Winston-Salem, NC 27109, USA. kingsb@wfu.edu

Free Radical Biology & Medicine
|August 12, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The red blood cell proteome and interactome identify a Band 3-BLVRB axis regulating hypoxic metabolic adaptation.

Blood·2026
Same author

Deep Red Blood Cell Proteome Defines the Band 3 N-Terminus Interactome as a Regulator of Hypoxic Adaptation via BLVRB-Dependent <i>S</i> -Nitroso Transfer.

bioRxiv : the preprint server for biology·2025
Same author

Differential reactivity of bacillithiol, mycothiol and glutathione with nitroxyl (HNO): Structural determinants and potential biological implications.

Redox biology·2025
Same author

Sulfinamide Formation from the Reaction of Bacillithiol and Nitroxyl.

ACS chemical biology·2023
Same author

Discovery of endogenous nitroxyl as a new redox player in Arabidopsis thaliana.

Nature plants·2022
Same author

Para-Substituted <i>O</i>-Benzyl Sulfohydroxamic Acid Derivatives as Redox-Triggered Nitroxyl (HNO) Sources.

Molecules (Basel, Switzerland)·2022
Same journal

Microglia-derived exosomal miR-31-5p promotes type 2 diabetic retinopathy by impairing physiological angiogenesis homeostasis.

Free radical biology & medicine·2026
Same journal

GPX1 Drives Cuproptosis-Ferroptosis Resistance in Cold Tumors.

Free radical biology & medicine·2026
Same journal

Frataxin attenuates endothelial inflammation triggered by engulfment of senescent erythrocytes.

Free radical biology & medicine·2026
Same journal

An enzyme kinetic model for quantitative interpretation of the role of nicotinamide nucleotide transhydrogenase (NNT) in cell physiology.

Free radical biology & medicine·2026
Same journal

Corrigendum to "The opposite role of lactate dehydrogenase a (LDHA) in cervical cancer under energy stress conditions" [Free Radic. Biol. Med. 214 (2024) 2-18].

Free radical biology & medicine·2026
Same journal

Complement C3a induces synaptic elimination in the hippocampus and neurobehavioral deficits in later life of septic neonatal rats triggered by lipopolysaccharide.

Free radical biology & medicine·2026
See all related articles

Hydroxyurea, a sickle cell disease treatment, may work by releasing nitric oxide. Studies explore how hydroxyurea generates nitric oxide in the body to improve therapies.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Hematology

Background:

  • Hydroxyurea is an emerging treatment for sickle cell disease (SCD).
  • Nitric oxide (NO) is also a promising therapeutic agent for SCD.
  • Hydroxyurea administration in SCD patients leads to increased iron nitrosyl hemoglobin and plasma nitrite/nitrate, suggesting in vivo NO generation.

Purpose of the Study:

  • To review in vitro studies investigating the mechanisms of in vivo nitric oxide (NO) release from hydroxyurea in sickle cell disease patients.
  • To elucidate the biochemical pathways responsible for NO generation from hydroxyurea.
  • To inform the development of novel hydroxyurea-derived NO donors for SCD treatment.

Main Methods:

  • Review of in vitro studies on hydroxyurea's NO-releasing properties.

Related Experiment Videos

  • Analysis of peroxidase-mediated NO formation from hydroxyurea.
  • Investigation of NO production following hydroxyurea hydrolysis to hydroxylamine.
  • Examination of structure-activity relationships for NO production.

    • Main Results:

    • Hydroxyurea reacts with hemoglobin, but these reactions are too slow to explain rapid in vivo increases in NO metabolites.
    • Peroxidase activity and hydrolysis to hydroxylamine are potential pathways for NO generation from hydroxyurea.
    • Structure-activity relationship studies are identifying key features for NO donation.

    Conclusions:

    • The precise mechanisms of in vivo nitric oxide release from hydroxyurea in sickle cell disease patients require further elucidation.
    • Understanding these pathways is crucial for optimizing hydroxyurea therapy and designing new NO-donating drugs.
    • Further research into hydroxyurea's NO-generating properties could lead to improved treatments for sickle cell disease.